title: Nanoparticles laden in situ gelling system for ocular drug targeting.
abstract: Designing an ophthalmic drug delivery system is one of the most difficult challenges for the researchers. The anatomy and physiology of eye create barriers like blinking which leads to the poor retention time and penetration of drug moiety. Some conventional ocular drug delivery systems show shortcomings such as enhanced pre-corneal elimination, high variability in efficiency, and blurred vision. To overcome these problems, several novel drug delivery systems such as liposomes, nanoparticles, hydrogels, and in situ gels have been developed. In situ-forming hydrogels are liquid upon instillation and undergo phase transition in the ocular cul-de-sac to form viscoelastic gel and this provides a response to environmental changes. In the past few years, an impressive number of novel temperature, pH, and ion-induced in situ-forming systems have been reported for sustain ophthalmic drug delivery. Each system has its own advantages and drawbacks. Thus, a combination of two drug delivery systems, i.e., nanoparticles and in situ gel, has been developed which is known as nanoparticle laden in situ gel. This review describes every aspects of this novel formulation, which present the readers an exhaustive detail and might contribute to research and development.
authors: Department of Pharmaceutics, School of Pharmacy, BIT, Meerut, Uttar Pradesh, India.
authors: Divya
authors: D
authors: Kumar
authors: Nidhi
authors: N
authors: Jain
authors: Neha
authors: N
authors: Gulati
authors: Upendra
authors: U
authors: Nagaich
keywords: Ion-activated in situ gel; in situ gel; ocular irritancy test; pH-based hydrogel; temperature sensitive in situ gel
references: J Cataract Refract Surg. 2003 Apr;29(4):632-3
references: 12686215
references: Acta Pharm. 2003 Dec;53(4):251-61
references: 14769232
references: Pak J Pharm Sci. 2009 Apr;22(2):175-9
references: 19339228
references: Pharm Res. 2003 Apr;20(4):584-90
references: 12739765
references: J Pharm Sci. 1995 Mar;84(3):344-8
references: 7616375
references: J Pharm Sci. 2003 Feb;92(2):407-13
references: 12532390
references: Eur J Pharm Sci. 2003 Sep;20(1):73-81
references: 13678795
references: Eur J Pharm Biopharm. 2004 Sep;58(2):409-26
references: 15296964
references: Invest Ophthalmol Vis Sci. 2000 Apr;41(5):1181-5
references: 10752958
references: Surv Ophthalmol. 1982 Jan-Feb;26(4):207-18
references: 7041308
references: J Adv Pharm Technol Res. 2010 Jul;1(3):291-6
references: 22247860
references: Surv Ophthalmol. 1993 May-Jun;37(6):435-56
references: 8100087
references: Biomaterials. 2007 Apr;28(11):2051-60
references: 17240443
references: Eur J Pharm Sci. 1998 Apr;6(2):105-12
references: 9795025
references: Adv Drug Deliv Rev. 2006 Nov 15;58(11):1131-5
references: 17097758
references: Pharm Res. 2009 May;26(5):1197-216
references: 18758924
references: Int J Pharm. 2002 Mar 2;234(1-2):205-12
references: 11839451
references: J Adv Pharm Technol Res. 2012 Jul;3(3):142-6
references: 23057000
references: Br J Ophthalmol. 1999 Jun;83(6):737-41
references: 10340986
references: Drug Dev Ind Pharm. 2002 May;28(5):473-93
references: 12098838
references: Int J Pharm. 2001 Jun 4;220(1-2):161-8
references: 11376978
references: Drug Discov Today. 2002 May 15;7(10):569-79
references: 12047857
references: AAPS PharmSciTech. 2010 Jun;11(2):610-20
references: 20354916
references: J Pharm Sci. 2002 Dec;91(12):2636-41
references: 12434408
references: J Ocul Pharmacol. 1994 Spring;10(1):47-56
references: 8207344
references: J Pharm Sci. 2011 Feb;100(2):681-91
references: 20803575
references: J Control Release. 2001 Jun 15;73(2-3):205-11
references: 11516498
references: Int J Pharm. 2004 May 19;276(1-2):83-92
references: 15113617
references: Exp Eye Res. 1977 Dec;25(6):577-82
references: 590384
references: J Control Release. 2002 Apr 23;80(1-3):9-28
references: 11943384
references: Eur J Pharm Sci. 1998 Apr;6(2):113-9
references: 9795027
references: Int J Pharm. 2000 Apr 20;199(2):119-27
references: 10802405
references: J Adv Pharm Technol Res. 2010 Jul;1(3):334-7
references: 22247867
references: J Control Release. 2007 Sep 26;122(2):119-34
references: 17719120
references: Clin Pharmacokinet. 1990 Apr;18(4):255-69
references: 2182264
references: Eur J Pharm Sci. 2002 Jul;16(1-2):53-61
references: 12113891
references: Drug Deliv. 2007 Nov;14(8):507-15
references: 18027180